Bone-scan-like pattern with Tc-99(m)(V)-DMSA scintigraphy in patients with osteomalacia and primary hyperparathyroidism

Akbunar A. T., Orhan B., Alper E.

NUCLEAR MEDICINE COMMUNICATIONS, cilt.21, sa.2, ss.181-185, 2000 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 21 Sayı: 2
  • Basım Tarihi: 2000
  • Doi Numarası: 10.1097/00006231-200002000-00010
  • Dergi Adı: NUCLEAR MEDICINE COMMUNICATIONS
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.181-185
  • Bursa Uludağ Üniversitesi Adresli: Evet

Özet

The aim of this study was to assess the role of Tc-99(m)(V)-dimercaptosuccinic acid (Tc-99(m)(V)-DMSA) scintigraphy in the evaluation of patients with metabolic bone disease. The study group comprised eight women aged 17-72 years, six with osteomalacia and two with primary hyperparathyroidism. Six patients were imaged scintigraphically before their treatments were started, whereas the other two underwent treatment during the time of examination. All six patients who had not previously been treated had prominent skeletal Tc-99(m)(V)-DMSA uptake, revealing a bone-scan-like pattern. In the two patients receiving medical therapy, their Tc-99(m)(V)-DMSA scans revealed a normal physiological distribution. Many of the fracture and pseudofracture sites detected on bone scans were also discerned with Tc-99(m)(V)-DMSA scintigraphy. Our results suggest that Tc-99(m)(V)-DMSA scintigraphy might have the potential as a screening method in patients with metabolic bone disease. ((C) 2000 Lippincott Williams & Wilkins).